BioCentury
biocentury.com
Actively hiring
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Europe's increasing NewCo interest
European VCs are spending more and more time in China, hunting for assets and building relationships that could produce NewCo investment opportunities in t...
Read more
Report
Biotech IPOs, CAR T safety, and pharma tariffs - a BioCentury podcast
Biotech IPO market - Electra's upsized $350 million offering that fell on its trading debut suggests investor demand remains open...
Read more
Report
BioCentury Grand Rounds U.S. Returns to Seattle in June to Break Down Translational Bottlenecks Between Innovation and Investment
SEATTLE, May 11, 2026--BioCentury Grand Rounds U.S. returns to Seattle June 3-5, bridging translational science research and drug development. Registration now open.
Read more
Report
Third death from a Sarepta gene therapy
A third patient, a 51 year-old in a Phase I study of SRP-9004 for limb-girdle muscular dystrophy Type 2E, has died from a Sarepta gene therapy.Like two dea...
Read more
Report
BioCentury Grand Rounds convenes in Chicago
BioCentury Grand Rounds in Chicago connects biopharma leaders to tackle R&D bottlenecks. Key sessions feature Marty Burke and Jonathon Sedgwick, fostering biotech innovation.
Read more
Report
Pro access
Upgrade to see all 16 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.